American Journal of Kidney Diseases
Volume 46, Issue 3 , Pages 406-414, September 2005

CKD Progression and Mortality Among Older Patients With Diabetes

Presented in part at the 37th Annual Meeting of the American Society of Nephrology, St Louis, MO, October 29–November 1, 2004.

Veterans Affairs Health Services Research and Development Center of Excellence, VA Ann Arbor Healthcare System; and Departments of Internal Medicine and Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, MI.

Received 8 April 2005; accepted 26 May 2005. published online 22 July 2005.

Background: Chronic kidney disease (CKD) is clearly associated with an increased risk for adverse outcomes; however, the cumulative impact of renal and cardiac complications in high-risk populations is not known. In addition, little is known about patterns of nephrology care in patients with CKD. Methods: We conducted a retrospective longitudinal cohort study assessing CKD prevalence and progression, associations with all-cause mortality, and variations in patterns of nephrology consultation in older patients with diabetes in a vertically integrated health care system. Results: A total of 12,570 patients within a 7–Veterans Affairs hospital service network in 1998 to 1999 were identified by means of computerized records. Nearly half (48%) were affected with CKD; most had mild to moderate CKD. After an observation period of 3 years, mortality rates in those unaffected with CKD were high (4.7 deaths/100 person-years) and increased substantially with progressive CKD (eg, 20.1 deaths/100 person-years with an estimated glomerular filtration rate [GFR] of 15 to 29 mL/min/1.73 m2 [0.25 to 0.48 mL/s/1.73 m2]). Only 7.2% of patients with CKD had a nephrology visit during the entire 5-year study period. Although visits increased with more advanced CKD, only 32% of patients with an estimated GFR of 15 to 29 mL/min/1.73 m2 had been seen in a nephrology clinic. We also found that nephrology referrals were driven preferentially by elevations in serum creatinine levels, rather than low GFRs. Conclusion: Many in this cohort of older patients with diabetes are affected with CKD. Mortality rates are high, and mortality risks associated with CKD amplify those of other risk factors. Nephrology visits are low and may represent an unexploited resource for improving CKD management. Underrecognition of CKD likely is related to overestimation of kidney function by relying on serum creatinine level in elderly patients.

Index Words:  Chronic kidney disease (CKD) , mortality , progression , cardiovascular disease , nephrology referral

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2005.05.027 on July 25, 2005.Supported in part by grant no. QUERI DIB 98-001 from The Office of Academic Affiliations and Health Services Research and Development, Department of Veterans Affairs; The Robert Wood Johnson Foundation; and grant no. P60 DK-20572 from the National Institute of Diabetes and Digestive and Kidney Diseases, The National Institutes of Health.

PII: S0272-6386(05)00777-8

doi:10.1053/j.ajkd.2005.05.027

American Journal of Kidney Diseases
Volume 46, Issue 3 , Pages 406-414, September 2005